Hofferberth Sophie C, Alexander Mark E, Mah Douglas Y, Bautista-Hernandez Victor, del Nido Pedro J, Fynn-Thompson Francis
Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
Arrhythmia Service, Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
J Thorac Cardiovasc Surg. 2016 Jan;151(1):131-8. doi: 10.1016/j.jtcvs.2015.08.064. Epub 2015 Aug 28.
OBJECTIVE(S): To assess the impact of univentricular versus biventricular pacing (BiVP) on systemic ventricular function in patients with congenitally corrected transposition of the great arteries (ccTGA).
We performed a retrospective review of all patients with a diagnosis of ccTGA who underwent pacemaker insertion. From 1993 to 2014, 53 patients were identified from the cardiology database and surgical records.
Overall mortality was 7.5% (n = 4). One patient required transplantation and 3 late deaths occurred secondary to end-stage heart failure. Median follow-up was 3.7 years (range, 4 days to 22.5 years). Twenty-five (47%) underwent univentricular pacing only, of these, 8 (32%) developed significant systemic ventricular dysfunction. Twenty-eight (53%) received BiVP, 17 (26%) were upgraded from a dual-chamber system, 11 (21%) received primary BiVP. Fourteen (82%) of the 17 undergoing secondary BiVP demonstrated systemic ventricular dysfunction at the time of pacer upgrade, with 7 (50%) demonstrating improved systemic ventricular function after pacemaker upgrade. Overall, 42 (79%) patients underwent univentricular pacing, with 22 (52%) developing significant systemic ventricular dysfunction. In contrast, the 11 (21%) who received primary BiVP had preserved systemic ventricular function at latest follow-up.
Late-onset systemic ventricular dysfunction is a major complication associated with the use of univentricular pacing in patients with ccTGA. All patients with ccTGA who develop heart block should undergo primary biventricular pacing, as this prevents late systemic ventricular dysfunction. Preemptive placement of BiVP leads at the time of anatomical repair or other permanent palliative procedure will facilitate subsequent BiVP should heart block develop.
评估单心室起搏与双心室起搏(BiVP)对先天性矫正型大动脉转位(ccTGA)患者体循环心室功能的影响。
我们对所有诊断为ccTGA并接受起搏器植入的患者进行了回顾性研究。1993年至2014年,从心脏病数据库和手术记录中识别出53例患者。
总死亡率为7.5%(n = 4)。1例患者需要进行移植,3例晚期死亡继发于终末期心力衰竭。中位随访时间为3.7年(范围为4天至22.5年)。25例(47%)仅接受单心室起搏,其中8例(32%)出现显著的体循环心室功能障碍。28例(53%)接受BiVP,17例(26%)从双腔系统升级而来,11例(21%)接受初次BiVP。在17例接受二次BiVP的患者中,14例(82%)在起搏器升级时出现体循环心室功能障碍,7例(50%)在起搏器升级后体循环心室功能得到改善。总体而言,42例(79%)患者接受了单心室起搏,其中22例(52%)出现显著的体循环心室功能障碍。相比之下,11例(21%)接受初次BiVP的患者在最近一次随访时体循环心室功能得以保留。
迟发性体循环心室功能障碍是ccTGA患者使用单心室起搏相关的主要并发症。所有发生心脏传导阻滞的ccTGA患者均应接受初次双心室起搏,因为这可预防晚期体循环心室功能障碍。在解剖修复或其他永久性姑息手术时预先放置BiVP导线,若发生心脏传导阻滞,将便于后续进行BiVP。